Related Experiment Video
Updated: Aug 8, 2026

Mouse Bladder Wall Injection
Published on: July 12, 2011
[The mechanism of p16 gene inactivation in human bladder transitional cell carcinoma]
Objective:
To figure out the mechanism of p16 gene inactivation in human bladder transitional cell carcinoma (BTCC).
Methods:
p16 gene was analyzed for genetic alterations by Southern blot analysis, PCR-SSCP and DNA methylation analysis in 52 cases of transitional cell carcinoma of bladder.
Results:
p16 gene deletion was found in 11 of 52 (21.15%) BTCCs, only one tumor showed point mutation on p16 exon 2, nineteen cases of BTCCs (36.53%) showed p16 gene 5' CpG island methylation.
Conclusion:
There was a statistically significant association between p16 gene deletion and early stage, well differentiated tumors. Additionally, a statistically significant correlation was also noticed between p16 gene 5' CpG island methylation and tumors in late stage with poor cell differentiation.
Insights
p16 gene inactivation in bladder cancer occurs through deletion or methylation. Deletion is linked to early-stage, well-differentiated tumors, while methylation correlates with late-stage, poorly differentiated tumors.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Context:
- Bladder transitional cell carcinoma (BTCC) is a significant human malignancy.
- Understanding gene inactivation mechanisms is crucial for cancer research.
Purpose:
- To investigate the mechanisms of p16 gene inactivation in human BTCC.
- To correlate genetic alterations of the p16 gene with tumor characteristics.
Summary:
- Analysis of 52 BTCC cases revealed p16 gene deletion in 21.15% and 5' CpG island methylation in 36.53%.
- A single tumor exhibited a point mutation in p16 exon 2.
- p16 gene deletion was associated with early-stage, well-differentiated tumors.
- p16 gene 5' CpG island methylation correlated with late-stage, poorly differentiated tumors.
Impact:
- Identifies key genetic alterations in p16 gene inactivation in BTCC.
- Provides insights into the differential roles of p16 deletion and methylation in bladder cancer progression.
- Establishes correlations between p16 alterations and clinicopathological features, aiding in understanding tumor behavior.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
Inhibition of Cdk Activity
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
DNA Damage Can Stall the Cell Cycle

